Aspek Diagnosis dan Tata Laksana Pancretic Neuroendocrine Tumor dengan Kecurigaan Insulinoma
Abstract
Insulinoma merupakan tumor neuroendokrin pankreas yang jarang ditemukan dan menjadi penyebab utama hipoglikemia endogen. Kasus: Laporan kasus ini menyajikan seorang pasien perempuan berusia 60 tahun dengan episode hipoglikemia berulang yang kemudian didiagnosis sebagai insulinoma pada ekor pankreas. Pasien datang dengan gejala neuroglikopenik berupa lemas, pusing, dan kebingungan yang sering muncul saat puasa atau setelah aktivitas fisik. Pemeriksaan laboratorium awal menunjukkan hipoglikemia berat disertai kadar insulin puasa yang tinggi. Pemeriksaan pencitraan menggunakan Magnetic Resonance Imaging (MRI) abdomen dengan kontras menunjukkan massa solid berukuran 4,2 × 3,3 cm pada kauda pankreas yang dicurigai sebagai insulinoma. Diskusi: Evaluasi lanjutan mengonfirmasi diagnosis insulinoma dengan lesi metastasis ke hati dan tulang, yang menunjukkan progresivitas tumor yang agresif. Kesimpulan: Modalitas diagnostik yang mutakhir dan pendekatan multidisiplin sangat penting untuk mengoptimalkan luaran pasien.
Kata kunci: insulinoma, hipoglikemia berulang, tumor neuroendokrin
Keywords
Full Text:
PDF (Bahasa Indonesia)References
La Rosa, S. and Sessa, F. Pancreatic Neuroendocrine Neoplasms: Practical Approach to Diagnosis, Classification, and Therapy. 2015. Springer.
Christ E, Antwi K, Fani M, Wild D. Innovative imaging of insulinoma: The end of sampling? a review. Vol. 27, Endocrine-Related Cancer. BioScientifica Ltd.; 2020. p. R79–92.
Gomez DM, Subasinghe D. Enucleation of a solitary pancreatic tail insulinoma: a case report and review of the literature. MedNEXT Journal of Medical and Health Sciences. 2024 Mar 8;5(2).
Câmara-de-Souza AB, Toyoshima MTK, Giannella ML, Freire DS, Camacho CP, Lourenço DM, et al. Insulinoma: A retrospective study analyzing the differences between benign and malignant tumors. Pancreatology. 2018 Apr 1;18(3):298–303.
Mahdi M, Almehman B, Nassan S, Binyahib S. Pancreatic insulinoma causing hypoglycemic episodes. J Pediatr Surg Case Rep. 2020 Jun 1;57.
Perkumpulan Endokrinologi Indonesia. Pedoman Pengelolaan dan Pencegahan Diabetes Melitus Tipe 2 Dewasa Di Indonesia 2021 [Internet].
[cited 2023 Jun 8]. Available from: https://pbperkeni.or.id/catalog-buku/pedoman-pengelolaan-dan-pencegahan-diabetes-melitus-tipe-2-di-indonesia-2021#
Okabayashi T, Shima Y, Sumiyoshi T, Kozuki A, Ito S, Ogawa Y, et al. Diagnosis and management of insulinoma. World J Gastroenterol. 2013 Feb 14;19(6):829–37.
Peltola E, Hannula P, Huhtala H, Metso S, Kiviniemi U, Vornanen M, et al. Characteristics and Outcomes of 79 Patients with an Insulinoma: A Nationwide Retrospective Study in Finland. Int J Endocrinol. 2018;2018:2059481.
Özaslan E, Karacan H, Şimşek Y, Bayram F. An Overview of Neuroendocrine Tumour Markers. Turkish Journal of Endocrinology and Metabolism. 2014 Dec 5;18(4):132–6.
Yang M, Zeng L, Ke N wen, Tan C lu, Tian B le, Liu X bao, et al. World Health Organization grading classification for pancreatic neuroendocrine neoplasms: a comprehensive analysis from a large Chinese institution. BMC Cancer. 2020 Dec 22;20(1):906.
Hofland J, Refardt JC, Feelders RA, Christ E, de Herder WW. Approach to the Patient: Insulinoma. Journal of Clinical Endocrinology and Metabolism. 2024 Apr 1;109(4):1109–18.
Luo Y, Pan Q, Yao S, Yu M, Wu W, Xue H, et al. Glucagon-like peptide-1 receptor PET/CT with 68Ga-NOTA-Exendin-4 for detecting localized insulinoma: A prospective cohort study. Journal of Nuclear Medicine. 2016 May 1;57(5):715–20.
de Carbonnières A, Challine A, Cottereau AS, Coriat R, Soyer P, Abou Ali E, et al. Surgical management of insulinoma over three decades. HPB. 2021 Dec 1;23(12):1799–806.
Haris B, Saraswathi S, Hussain K. Somatostatin analogues for the treatment of hyperinsulinaemic hypoglycaemia. Ther Adv Endocrinol Metab. 2020 Jan 2;11.
Antonakis PT, Ashrafian H, Martinez-Isla A. Pancreatic insulinomas: Laparoscopic management. World J Gastrointest Endosc. 2015;7(16):1197.
Friebe L, Freitag MT, Braun M, Nicolas G, Bauman A, Bushnell D, et al. Peptide Receptor Radionuclide Therapy Is Effective for Clinical Control of Symptomatic Metastatic Insulinoma: A Long-Term Retrospective Analysis. Journal of Nuclear Medicine. 2024 Feb 10;65(2):228–35.
Krug S, Gress TM, Michl P, Rinke A. The Role of Cytotoxic Chemotherapy in Advanced Pancreatic Neuroendocrine Tumors. Digestion. 2017;96(2):67–75.
Boyiadzis MM, Fojo T. Hematology-Oncology Therapy, Third Edition. 3rd Edition. Vol. 1. McGraw Hill ; 2022.
Longo DL. Harrison’s Hematology and Oncology, Third Edition. 3rd edtion. Boston, MA: McGraw Hill ; 2016.
Masharani U, Lindsay S, Moon F, Paciorek A, Bergsland E. Metastatic insulinoma—outcomes in the current era. Oncologist. 2024 Oct 30;
Ramage J, Naraev BG, Halfdanarson TR. Peptide receptor radionuclide therapy for patients with advanced pancreatic neuroendocrine tumors. Vol. 45, Seminars in Oncology. W.B. Saunders; 2018. p. 236–48.
Walker MP, Shenoy V, Metz DC, Stanley CA, Fraker D, Chandrasekhara V, et al. Case presentation of 8-year follow up of recurrent malignant duodenal Insulinoma and lymph node metastases and literature review of malignant Insulinoma management. BMC Endocr Disord. 2022 Dec 1;22(1).
DOI: https://doi.org/10.30596/amj.v9i3.30938
Refbacks
- There are currently no refbacks.

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Jurnal Kedokteran Anatomica/ Anatomica Medical Journal (AMJ)
E-mail: amj_fk@umsu.ac.id || Editorial Contact: 081375150018
This work is licensed under aCreative Commons Attribution-ShareAlike 4.0 International License.
.png)
